Google
×
Investor Relations · Latest News · Aurinia Receives Exemptive Relief from Canadian Securities Regulators for Share Repurchase Program · Aurinia to Participate in ...
Investor Relations. ir@auriniapharma.com. Clinical Trials. clinicaltrials@auriniapharma.com. Medical Information. medinfo@auriniapharma.com. Corporate ...
Find annual and quearterly earnings data for Aurinia Pharmaceuticals Inc Ordinary Shares (AUPH) including earnings per share, earnings forecasts at ...
Feb 16, 2024 · Aurinia Pharmaceuticals Inc. misses on earnings expectations. Reported EPS is $-0.19 EPS, expectations were $-0.18. AUPH isn't one of the 30 ...
$5.49
Find the latest SEC Filings data for Aurinia Pharmaceuticals Inc Ordinary Shares (AUPH) including 10-K and 10-Q forms at Nasdaq.com.
Head of the Corporate Communications & Investor Relations, N/A, N/A, N/A. Mr. Fran Lynch, Vice President of Sales, N/A, N/A, N/A. Mr. Michael R. Martin, Chief ...
Feb 15, 2024 · (AUPH) Q4 2023 Earnings Call Transcript ... Andrea Christopher - Head, Corporate Communications & Investor Relations ... About AUPH Stock. Symbol ...
Aug 3, 2023 · (AUPH) Q2 2023 Earnings Call Transcript. Aug. 03 ... Investor Relations for Aurinia Pharmaceuticals. ... About AUPH Stock. Symbol, Last Price, % Chg ...
Feb 27, 2024 · Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) announces participation in upcoming investor conferences in March 2024, including TD Cowen's 44th ...
Jul 15, 2022 · Aurinia Pharmaceuticals hired a trio of executives in a move that suggests it's nowhere near a buyout — and AUPH stock plummeted Friday.